Expert’s View is a regular feature on WorkersCompensation.com that shares insights and opinions from leaders and stakeholders in the workers’ comp industry. After the launch of the 2019 myMatrixx Drug Trend Report, our Chief Clinical Officer, Phil Walls, published an article detailing some of the important findings the report contains. The piece, entitled “Five Workers’ Comp Drug Trends That Will Drive the Industry in 2020 and Beyond” covers topics ranging from decreasing opioid utilization to understanding the effects of an aging workforce.
Regarding opioid utilization, Walls discusses how myMatrixx and our efforts to create an expansive pharmacovigilance strategy led to a 10.7% decline in opioid spending last year, part of a consecutive five-year decline. Other talking points include increasing generic substitution and managing specialty drug spend. You can read the full article here.